Search results for: 'Diagnostics Lab Automation and Monitoring Solutions Growth Opportunities'

This study analyzes several patient monitoring devices, such as blood pressure monitors, fetal and maternal monitors, multiparameter monitors, pulse oximeters, and spirometers. It addresses critical questions such as industry size, growth rates, growth opportunities, strategic imperatives, technology impact, and new business models. Regional covera...

31 Jul 2023  |  North America  |  Market Research

Global Oncology Diagnostics in IVD Growth Opportunities

By Leveraging Data-driven Solutions, Co-development Opportunities, and Assay Innovation, Clients Can Experience Enhanced Product Performance, Cost-effectiveness, and Improved Decision-making Capabilities

Infographics

×

The global oncology diagnostics in IVD market is expected to witness significant growth, driven by an increase in cancer incidence, technological developments in diagnostic tests, the growing number of screening tests, and supportive government initiatives. Owing to the intense competition in the market, the most prominent companies are investing h...

27 Aug 2020  |  Global  |  Market Research

Smart Labs as Key Drivers for the Digital Transformation of Diagnostic Laboratories, 2020

Robotic Automation, Internet of Things (IoT), and Artificial Intelligence (AI) Offering Growth Opportunities for Academic and Commercial Diagnostics Labs

Infographics

×

Key Issues Addressed

Diagnostic academic and commercial research labs suffer from cost pressures, given the ongoing Protecting Access to Medicare Act (PAMA) regulations and reproducibility issues, and are under productivity strain. The recent COVID-19 pandemic leading to increasing test volumes and renewed focus on research and development (R&D) to drive innovation wil...

19 Jun 2024  |  Global  |  Technology Research

Molecular Diagnostics for Neurodegenerative Diseases: Technology Growth Opportunities, 2024 2028

Leveraging integrated and point-of-care diagnostics with multiomics represents the most promising growth opportunity to advance molecular diagnostics for neurodegenerative diseases

Infographics

×

Neurodegenerative diseases (NDD) pose significant challenges to healthcare systems and affect millions of people worldwide, making early detection crucial. While the current diagnostic strategy is predominantly brain imaging techniques, it is not performed until symptoms are more pronounced. Subtle changes occurring in neural cells during early pro...

The care delivery model is shifting from hospitals to alternative care settings, such as home care and ambulatory surgical centers. Multiple challenges in hospitals, including a severe shortage of skilled workforce, staff burnout, and declining margins, boost this shift. The adoption of multiparameter monitoring devices in out-of-hospital settings ...

15 May 2023  |  North America  |  Market Research

Global Continuous Glucose Monitoring Solutions Market, 2027 Forecast

Opportunities in Type 2 Diabetic and Non diabetic Patients Treatment Boost Future Growth Potential

Infographics

×

The rising prevalence of diabetes entails a greater need for treatment and monitoring. In this context, multiple growth opportunities arise in the continuous glucose monitoring (CGM) solutions market. CGM devices have been extensively used for Type 1 diabetes patients. With further technological development and clinical studies, CGM’s applications ...

Clinical diagnostics, life science research, genomics and proteomics, and drug discovery labs are adopting lab automation solutions to overcome tremendous operational pressure because of the demand for high throughput and shortage of technicians. Solutions that automate pre-analytical, analytical, and post-analytical processes are available. The re...

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) ) profiles a wide range of innovations from the advanced medical devices, medical imaging, and diagnostics industry. The issue includes advanced medical devices such as pneumatic compression device, minimally invasive devices, robotic surgery platform, fixation medical device,...

The concept of companion diagnostics (CDx) was developed when researchers realized that even potent drugs only had an efficacy between 25% and 60%, the lowest being in oncology. Therefore, a clinical pharmacogenetic assay became important to distinguish patients more likely to respond to a drug or at a lesser risk of associated adverse pathophysiol...